BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 28938797)

  • 1. Revisiting the safety of aspartame.
    Choudhary AK; Pretorius E
    Nutr Rev; 2017 Sep; 75(9):718-730. PubMed ID: 28938797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiological symptoms and aspartame: What is the connection?
    Choudhary AK; Lee YY
    Nutr Neurosci; 2018 Jun; 21(5):306-316. PubMed ID: 28198207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspartame. Review of safety issues. Council on Scientific Affairs.
    JAMA; 1985 Jul; 254(3):400-2. PubMed ID: 2861297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxic Effect of Aspartame as an Artificial Sweetener: a Brief Review.
    Ardalan MR; Tabibi H; Ebrahimzadeh Attari V; Malek Mahdavi A
    Iran J Kidney Dis; 2017 Oct; 11(5):339-343. PubMed ID: 29038387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term administration of aspartame on biochemical indices, lipid profile and redox status of cellular system of male rats.
    Adaramoye OA; Akanni OO
    J Basic Clin Physiol Pharmacol; 2016 Jan; 27(1):29-37. PubMed ID: 26247507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.
    Magnuson BA; Burdock GA; Doull J; Kroes RM; Marsh GM; Pariza MW; Spencer PS; Waddell WJ; Walker R; Williams GM
    Crit Rev Toxicol; 2007; 37(8):629-727. PubMed ID: 17828671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carcinogenic effects of aspartame: The urgent need for regulatory re-evaluation.
    Soffritti M; Padovani M; Tibaldi E; Falcioni L; Manservisi F; Belpoggi F
    Am J Ind Med; 2014 Apr; 57(4):383-97. PubMed ID: 24436139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro cytotoxic, genotoxic, and oxidative damage potentials of the oral artificial sweetener aspartame on cultured human blood cells.
    Çadirci K; Özdemir Tozlu Ö; Türkez H; Mardinoğlu A
    Turk J Med Sci; 2020 Apr; 50(2):448-454. PubMed ID: 32222132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and biochemical effects of monosodium glutamate and aspartame, administered individually and in combination in male albino mice.
    Abu-Taweel GM; A ZM; Ajarem JS; Ahmad M
    Neurotoxicol Teratol; 2014; 42():60-7. PubMed ID: 24556450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspartame and Phe-Containing Degradation Products in Soft Drinks across Europe.
    van Vliet K; Melis ES; de Blaauw P; van Dam E; Maatman RGHJ; Abeln D; van Spronsen FJ; Heiner-Fokkema MR
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32599819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Aspartame: A review of genotoxicity data".
    Kirkland D; Gatehouse D
    Food Chem Toxicol; 2015 Oct; 84():161-8. PubMed ID: 26321723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of long-term effects of artificial sweeteners on rat brain: a biochemical, behavioral, and histological study.
    Erbaş O; Erdoğan MA; Khalilnezhad A; Solmaz V; Gürkan FT; Yiğittürk G; Eroglu HA; Taskiran D
    J Biochem Mol Toxicol; 2018 Jun; 32(6):e22053. PubMed ID: 29660801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the genotoxic and carcinogenic effects of aspartame: does it safe or not?
    Yılmaz S; Uçar A
    Cytotechnology; 2014 Dec; 66(6):875-81. PubMed ID: 24510317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential intake of intense sweeteners in Brazil.
    Toledo MC; Ioshi SH
    Food Addit Contam; 1995; 12(6):799-808. PubMed ID: 8608854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspartame and Soft Drink-Mediated Neurotoxicity in Rats: Implication of Oxidative Stress, Apoptotic Signaling Pathways, Electrolytes and Hormonal Levels.
    Lebda MA; Sadek KM; El-Sayed YS
    Metab Brain Dis; 2017 Oct; 32(5):1639-1647. PubMed ID: 28660358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspartame, low-calorie sweeteners and disease: regulatory safety and epidemiological issues.
    Marinovich M; Galli CL; Bosetti C; Gallus S; La Vecchia C
    Food Chem Toxicol; 2013 Oct; 60():109-15. PubMed ID: 23891579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartame: review of safety.
    Butchko HH; Stargel WW; Comer CP; Mayhew DA; Benninger C; Blackburn GL; de Sonneville LM; Geha RS; Hertelendy Z; Koestner A; Leon AS; Liepa GU; McMartin KE; Mendenhall CL; Munro IC; Novotny EJ; Renwick AG; Schiffman SS; Schomer DL; Shaywitz BA; Spiers PA; Tephly TR; Thomas JA; Trefz FK
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 2):S1-93. PubMed ID: 12180494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of aspartame in the soft drinks: Identification of the novel phototransformation products and their toxicity evaluation.
    Trawiński J; Skibiński R
    Food Res Int; 2023 Nov; 173(Pt 1):113365. PubMed ID: 37803662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Effect of Aspartame on Ionic Homeostasis and Monoamine Neurotransmitters in the Rat Brain.
    Abhilash M; Alex M; Mathews VV; Nair RH
    Int J Toxicol; 2014 Jul; 33(4):332-341. PubMed ID: 24872471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racemization of aspartic acid and phenylalanine in the sweetener aspartame at 100 degrees C.
    Boehm MF; Bada JL
    Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5263-6. PubMed ID: 6591191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.